Related Experiment Videos
Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop
Hideki Nakajima1, Laurence Cocquerel, Nobutaka Kiyokawa
1Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, CA, USA.
Biochemical and Biophysical Research Communications
|February 15, 2005
Summary
This study analyzed the interaction kinetics between CD81 and hepatitis C virus (HCV) envelope proteins using BIAcore. Results show HCV envelope protein heterogeneity influences binding strength with CD81 large extracellular loop (CD81LEL).
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- Hepatitis C virus (HCV) entry into host cells is mediated by interactions between viral envelope proteins and host cell receptors.
- CD81, a tetraspanin protein, is a known host factor involved in HCV infection, interacting with the HCV envelope glycoproteins E1 and E2.
- Understanding the molecular details of CD81-HCV envelope protein interactions is crucial for developing antiviral strategies.
Purpose of the Study:
- To kinetically characterize the interactions between CD81 large extracellular loop (CD81LEL) and different forms of HCV envelope proteins (E1E2, E2, E2(661)).
- To investigate the influence of CD81LEL fusion protein forms (multimeric GST vs. monomeric MBP) on binding kinetics.
- To elucidate the nature of CD81-HCV envelope protein interactions using binding models.
Main Methods:
- Surface plasmon resonance (SPR) using BIAcore technology to analyze binding kinetics.
- Immobilization of various HCV envelope proteins (E1E2, E2, E2(661)) onto sensor chips.
- Injection of CD81LEL fused to glutathione-S-transferase (CD81LEL-GST) or maltose binding protein (CD81LEL-MBP) to measure association and dissociation rate constants.
Main Results:
- Similar association rate constants were observed for both CD81LEL-GST and CD81LEL-MBP with all tested HCV envelope proteins.
- CD81LEL-MBP exhibited higher dissociation rate constants compared to CD81LEL-GST, indicating faster dissociation.
- The dissociation rate of CD81LEL-GST from E1E2 was significantly lower than from E2 or E2(661), suggesting stronger binding to the E1E2 complex.
- The interaction kinetics best fitted the 'heterogeneous ligand' model, implying the presence of both strong and weak binding sites.
- This heterogeneity is likely attributed to the structural properties of HCV envelope proteins, including heterodimers and aggregates.
Conclusions:
- The binding affinity between CD81LEL and HCV envelope proteins is influenced by the multimeric state of CD81LEL and the specific form of the HCV envelope protein.
- HCV envelope proteins present a heterogeneous binding surface to CD81LEL, characterized by distinct strong and weak interaction components.
- These findings provide insights into the molecular basis of CD81-mediated HCV entry and potential targets for therapeutic intervention.